Comprehensive Overview of Cataract, Pterygium, and Pseudophakia
CATARACT
Definition and Pathophysiology
A cataract is a degradation of the optical quality of the crystalline lens that affects vision, most commonly related to aging and occurring in one or both eyes 1. The condition represents the leading cause of blindness worldwide and the leading cause of visual impairment among all ethnic and racial backgrounds in the United States 1.
Types and Clinical Presentation
The three most common types are:
Nuclear cataract: Central opacification or discoloration (brunescent or opalescent) that progresses slowly and primarily affects distance vision more than near vision 1
Cortical cataract: Can be central or peripheral, appearing as opaque spokes or oil droplets. Patients commonly complain of glare, and when the entire cortex becomes opaque, it's termed a mature cortical cataract 1
Posterior subcapsular cataract (PSC): Located just inside the posterior lens capsule, causes substantial visual impairment when involving the axial region. Patients experience glare symptoms, poor vision in bright light, and near vision is typically more affected than distance due to miosis with accommodation 1
Epidemiology
The risk increases with each decade of life starting around age 40. In the United States, cases are forecasted to double from 24.4 million to approximately 50 million by 2050 1.
Treatment Approach
Medical Management
There is insufficient evidence to support pharmacological treatments for cataract prevention or progression retardation 1. Patients using long-term topical ophthalmic, periocular, oral, or inhaled corticosteroids should be informed of increased cataract risk 1.
Surgical Management
The predominant method is sutureless, small-incision phacoemulsification with foldable IOL implantation performed on an outpatient basis 1. Phacoemulsification produces better uncorrected distance visual acuity and lower surgical complication rates (iris prolapse, posterior capsule rupture) compared to manual extracapsular cataract extraction 1.
Indications for Surgery
The primary indication is a decline in visual function that no longer meets the patient's visual needs and for which surgery provides reasonable likelihood of improvement 1. Additional indications include:
- Clinically significant anisometropia with cataract present
- Lens opacity interfering with diagnosis/management of posterior segment pathology
- Lens-induced inflammation and secondary glaucoma (phacolytic, lens particle, phacoantigenic)
- Lens-induced primary angle closure or other lens-related glaucoma 1
Contraindications
Surgery should NOT be performed when:
- Tolerable refractive correction meets patient's needs
- Surgery not expected to improve visual function with no other indication
- Patient cannot safely undergo surgery due to medical/ocular conditions
- Appropriate postoperative care cannot be arranged
- Informed consent cannot be obtained 1
Preoperative Evaluation
The operating ophthalmologist must:
- Perform comprehensive preoperative examination
- Obtain informed consent discussing risks, benefits, and expected outcomes
- Counsel about postoperative refractive options (bilateral emmetropia, bilateral myopia, monovision)
- Discuss specialty IOL options (toric, multifocal, extended depth of focus, accommodating, postoperatively adjustable)
- Assess ocular comorbidities and their impact on surgical outcomes
- Formulate surgical plan including anesthesia selection, surgical approach, and IOL design/power 1
Postoperative Care and Complications
Topical NSAIDs reduce the incidence of early postoperative cystoid macular edema (CME), though long-term benefit has not been demonstrated 1. Intracameral antibiotic administration substantially reduces the risk of postoperative bacterial endophthalmitis, and increasing evidence suggests topically applied antibiotics do not add benefit beyond intracameral injection 1.
Key postoperative management includes:
- Treatment of elevated intraocular pressure
- Management of corneal edema
- Visual rehabilitation
- Monitoring for complications 1
Advanced Surgical Considerations
Femtosecond laser-assisted cataract surgery (FLACS) increases capsulorrhexis circularity and centration, and reduces ultrasonic energy required, but is not yet cost-effective and overall risk profile and refractive outcomes have not proven superior to standard phacoemulsification 1.
PTERYGIUM
Definition and Pathophysiology
Pterygium is a frequent ultraviolet (UV) light-induced focal fibrovascular proliferation of conjunctival tissue onto the cornea 2. This represents a significant ocular surface disorder that can substantially impact visual outcomes and surgical planning.
Clinical Presentation
Pterygium causes:
- Progressive astigmatism
- Potential invasion of the optical axis
- Ocular surface complaints
- Reduced visual acuity when advanced 2
Surgical Indications
Surgical excision should be performed for reduced visual acuity, progressive astigmatism, impending invasion of the optical axis, and ocular surface complaints 2.
Surgical Technique
The main factors preventing recurrence include optimal surgical treatment by excision combined with free conjunctival autograft, consistent postoperative treatment with preservative-free artificial tears and topical steroids, and long-term UV protection 2.
Impact on Cataract Surgery
Pterygium causes significant errors in IOL power calculation, with greater pterygium length/area exerting larger effects 3. Specifically:
- Pterygia with horizontal length of 1.73 mm and area of 4.45 mm² create 0.5 diopter errors in calculated IOL power
- Pterygia with horizontal length of 2.25 mm and area of 6.95 mm² create 1.0 diopter errors 3
- Pterygia with horizontal length >1.83 mm and area >5.1 mm² create 2.0 diopter errors in anterior corneal astigmatism 3
Timing of Combined Surgery
Cataract surgery with IOL implantation is recommended ≥6 months after pterygium surgery 3. The calculated IOL power values changed significantly from preoperative to 6 months postoperatively but did not change significantly from 6 to 12 months, establishing this as the optimal waiting period 3.
In combined cases, calculated IOL power should be decreased by 0.5 to 1.5 diopters based on the pterygium length/area 3.
Simultaneous Surgery Outcomes
When pterygium and cataract surgery are performed simultaneously:
- Recurrence rates can reach 40% 4
- Visual recovery to 6/12 or better achieved in 63% of cases 4
- Post-operative astigmatism remains a concern (mean with-the-rule astigmatism 1.3 D, mean against-the-rule astigmatism 1.2 D) 4
Light Adjustable Lens Option
For patients facing logistical challenges with the traditional 2-stage approach, simultaneous pterygium and cataract surgery with light adjustable lens (LAL) implantation offers a viable alternative 5. The adjustability of the LAL mitigates refractive unpredictability caused by corneal irregularities, with 83% of eyes achieving spherical equivalent <0.5 diopters at 3 months 5.
Postoperative Considerations
Pterygium excision disrupts ocular surface homeostasis through corneal denervation, inflammation, goblet cell loss, and meibomian gland dysfunction 6. This requires multimodal postoperative therapy including preservative-free artificial tears and topical steroids 2.
PSEUDOPHAKIA
Definition
Pseudophakia refers to the state of having an artificial intraocular lens (IOL) implanted in the eye following cataract extraction, replacing the natural crystalline lens.
IOL Options and Selection
The ophthalmologist must counsel patients about various IOL options 1:
- Standard monofocal IOLs: For single focal point vision
- Toric IOLs: For astigmatism correction
- Multifocal IOLs: For multiple focal points
- Extended depth of focus IOLs: For enhanced range of vision
- Accommodating IOLs: Designed to change focus
- Postoperatively power adjustable IOLs: Allow refractive adjustments after surgery
Refractive Planning
Patients should be counseled about postoperative refractive options including bilateral emmetropia, bilateral myopia, or monovision, based on ophthalmic history and patient desires 1. The surgeon must establish criteria for successful treatment outcomes with the patient, including working distances and potential limitations 1.
Special Considerations for Hypermetropic Eyes
In hypermetropic eyes requiring high-power IOLs, primary polypseudophakia (implantation of two IOLs within the capsular bag) can be considered. Studies show spherical equivalent reduction from mean +4.87 diopters to -0.12 diopters, with 93.33% of eyes within 2 diopters of intended refraction 7.
Complications and Management
Pseudophakic Cystoid Macular Edema (PCME)
PCME is a common complication of cataract surgery that may rarely result in vision loss 8. In most cases, PCME resolves spontaneously, making it challenging to establish efficacy of therapeutic interventions 8. Most surgeons advocate prophylaxis primarily for high-risk eyes 8.
Topical NSAIDs reduce the incidence of early postoperative CME, but long-term benefit has not been demonstrated 1. The integrity of the posterior lens capsule plays a major role in the pathogenesis of this complication 9.
Interlenticular Opacification (ILO)
In polypseudophakia cases, peripheral Elschnig pearl-type ILO can occur as a late complication (26.67% of cases), and a new type of ILO with pigmented deposits in the central interface can develop (33.33% of cases), sometimes resulting in Newton's rings 7. However, these have not resulted in deterioration of visual acuity to date 7.
Uveitis-Glaucoma-Hyphema Syndrome
The sole indication for IOL removal is the uveitis-glaucoma-hyphema syndrome 9.
Postoperative Care
Regular administration of corticosteroids is essential in post-operative treatment of pseudophakia, though this may mask bacterial or mycotic infection 9. Early postoperative aims include:
- Rapid mobilization
- Complete absence of irritation
- Normalization of intraocular pressure 9
Ocular Surface Considerations
Compromised ocular surface status can interfere with decision-making regarding cataract surgery technique, preoperative biometry for IOL power calculation, and intraoperative visibility 10. Stabilization of the ocular surface by medical or surgical means, and appropriate management of underlying immune etiology, helps optimize cataract outcomes 10.
Pre, intra, and postoperative tools such as punctal occlusion, ocular surface reconstruction, systemic immunosuppression, illuminators, capsule staining dyes, and PROSE lenses can maximize visual outcomes in eyes with ocular surface disorders 10.
Safety and Quality of Life Impact
Cataract surgery with successful pseudophakia improves patient safety by reducing the risk of traffic accidents, falls, and fractures 1, directly addressing mortality and quality of life outcomes that should guide all treatment decisions.